Company profile
Generate Biomedicines, Inc. Insider Trading
GENBEvery SEC Form 4 insider trading filing for Generate Biomedicines, Inc. (GENB) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002100782
- Filings
- 16
- Insiders
- 27
- Last filing
- 2026-03-04
Activity summary
No insider transactions in the last 30 days. The most recent was on March 4, 2026, when Nally Michael bought 20,000 shares. 16 filings from 27 insiders are on record below.
No insider activity recorded for GENB in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Nally Michael | GENB | Purchase | 20,000 | $12.00 | $240K |
| Mar 2, 2026 | Afeyan Noubar | GENB | Purchase | 1,562,500 | $16.00 | $25.00M |
| Mar 2, 2026 | Afeyan Noubar | GENB | Purchase | 1,562,500 | $16.00 | $25.00M |
| Mar 2, 2026 | Afeyan Noubar | GENB | Purchase | 1,562,500 | $16.00 | $25.00M |
| Mar 2, 2026 | Afeyan Noubar | GENB | C | 12,723,940 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=GENB" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Generate Biomedicines, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →